Nuformix Share Discussion Threads

[the imperialist] 29/1/2024 13:13

I tend to blindly stick a few bags in these potential multi-baggers and ignore the chart. Not life changing amounts, so no issue, just frustrating, and further illustration that the UK markets are shyte.

[daar] 29/1/2024 13:00

Wtf happening?

[the imperialist] 23/1/2024 07:58

The levels on the chart are 4-7p, so you guys aren't far off.

I bought my first tranche at 6p! :-(

[peverill] 23/1/2024 07:46

7-10p hopefully.

[jotoha2] 22/1/2024 21:18

Chart is looking nice , where is the news to justify this little tick up , when it comes it should be magical , 1/2/3p take your choice.

[institutional investments] 22/1/2024 10:28

Not sure if will today. 50:50

But it actually will do anyway. With a big move so maybe on a release

[institutional investments] 22/1/2024 10:20

Bit of movement at last

Perfect timing in every way

Just need crack 0.44 and it's away

Should do

[institutional investments] 12/1/2024 09:20

Any partnerships that are lsnstead finance style, fast exit 😂

[institutional investments] 12/1/2024 09:08

Well, 3-6p seems reasonable as a buyout. Don't think it can get there any time soon as is. Would need to raise money given the span . Unless announce a licence deal with AZN or something. Even an understanding announced would do

[institutional investments] 12/1/2024 09:07

Off book far more interesting than L2

[the imperialist] 12/1/2024 08:59

Deal must have been leaked. They're talking 3-6p in the group.

[institutional investments] 10/1/2024 13:26

Don't know. But something is anyway. A deal would make more sense than licencing for some .

Even if to ice it lol

[the imperialist] 10/1/2024 13:25

Is there a deal on the table?

[institutional investments] 10/1/2024 13:22

Wherever it is, pretty much a confirmed now

[markstevenkirby80] 10/1/2024 01:03

Nor be long and up we go

[institutional investments] 10/1/2024 01:02

Big power this week yet it doesn't seem like news is due this week . Very strange mix . Unless a surprise release

[institutional investments] 10/1/2024 01:01

Nearly a 52 week high too lol

[shearluc] 10/1/2024 00:52

omfg This has really sunk to a NEW low

[institutional investments] 10/1/2024 00:07

A bit surprised with the restraint on share price post that. Would have been enough to hit a quid in a natural market

Shall dig deeper

[institutional investments] 10/1/2024 00:03

I think AZN will be interested in taking over here for obvious reasons

[institutional investments] 10/1/2024 00:00

The Group discovered novel forms of olaparib, a drug currently marketed by AstraZeneca, as Lynparza®. Lynparza® was first approved in December 2014 for the treatment of adults with advanced ovarian cancer and deleterious or suspected deleterious germline BRCA mutation. Since then, it has secured similar approvals in breast, pancreatic and prostate cancers with further trials on-going. These approvals have propelled Lynparza® sales to US$2.6bn in 2022 with industry analysts forecasting annual sales of US$9.7bn by 2028.

The Group has filed two patent applications on its novel forms of olaparib with the potential for patent life to 2040/2041.

The Company demonstrated enhanced performance of NXP004 cocrystals compared to olaparib. Subsequently, further preformulation studies allowed the Company to identify lead cocrystals to be progressed for further development.

Results from in vitro dissolution studies demonstrated that the two lead NXP004 cocrystals out-performed Lynparza®, both in terms of rate and extent of dissolution and release of olaparib.

[vlad the impaler] 08/1/2024 12:17

Very hard to determine if the recent cluster of power days (since November 23 )is because news imminently expected, or a build for later news. I guess that doesn't matter. Just keep on loading